parkinson-disease

Documents about parkinson-disease

• Genetic landscape of Parkinson’s disease in the Personalized Parkinson Project cohort#395174Europe PMC
• The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease#858392ClinicalTrials.gov
• An Online Physical Activity Coaching Intervention for People With PD in Qatar#844292ClinicalTrials.gov
• A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease#830387ClinicalTrials.gov
• Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease#846853ClinicalTrials.gov
• From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease#676399Europe PMC
• Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts#676462Europe PMC
• Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression#800591ClinicalTrials.gov
• Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET#800615ClinicalTrials.gov
• CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease#805387ClinicalTrials.gov
• Local Fields Potentientals of the Subthalamic Nucleus in Patients With Parkinson's Disease#807356ClinicalTrials.gov
• Effect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease#810986ClinicalTrials.gov
• Studying Automatic Movements in Patients With Parkinson's Disease#834396ClinicalTrials.gov
• Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease#836840ClinicalTrials.gov
• Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact#850742ClinicalTrials.gov
• Short Pulse Width Versus Low Frequency DBS in Parkinson's Disease#856700ClinicalTrials.gov
• Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease#858695ClinicalTrials.gov
• Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease#860251ClinicalTrials.gov
• Effects of Osteopathic Manipulative Treatment on Postural Control in Parkinson's Disease/Pisa Syndrome Patients#860659ClinicalTrials.gov
• Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease#832801ClinicalTrials.gov
• Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off#841452ClinicalTrials.gov
• Systemic Synuclein Sampling Study (S4)#843230ClinicalTrials.gov
• Associations of Non-motor Symptoms with Perceptual Speech Impairments in Parkinson’s Disease#433027DigitalCommons@SHU
• A dança como recurso terapêutico complementar em saúde mental na doença de Parkinson#686853RIUFPA
• Machine learning combined with WGCNA reveals potential calcium uptake-associated biomarkers in Parkinson's disease.#181845PubMed
• Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial#800400ClinicalTrials.gov
• Combining rTMS and Video Game-based Dexterity Training to Improve Dexterity in Parkinson's Disease#826708ClinicalTrials.gov
• Robotic Gait Rehabilitation in Parkinson's Disease#828735ClinicalTrials.gov
• Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease#839517ClinicalTrials.gov
• Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease#840163ClinicalTrials.gov
• Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients#854738ClinicalTrials.gov
• JAME, a Wearable Device to Control Tremor#857770ClinicalTrials.gov
• Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease#123209Europe PMC
• Non-invasive Diagnosis of Parkinson's Disease#838464ClinicalTrials.gov
• Genetic landscape of Parkinson’s disease in the Personalized Parkinson Project cohort#130543Unpaywall
• A High-density Microelectrode for Human Neuronal Recordings#840866ClinicalTrials.gov
• Cognitive Rehabilitation With Virtual Reality in Parkinson Disease#849207ClinicalTrials.gov
• Chinese PD Registry#387244ClinicalTrials.gov
• Ending Parkinson's Disease#466045Open Library
• ANN for Parkinson’s Disease Prediction#764715PhilArchive
• Spike RBD drives sustained Parkinson's disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation#205505Europe PMC
• Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease#250650IRIS
• Intestinal histomorphological and molecular alterations in patients with Parkinson's disease#304794IRIS
• Experiences of Pacific Peoples and their ‘āiga/kāinga/kāiga/vuvale living with Parkinsons: A qualitative study#450189PLOS
• DBS-related infections in Parkinson's disease: Incidence, risk factors, management and outcome#635205HAL (France)
• Deficits in episodic memory and executive functions in relation to CB1 receptor availability in Parkinson's disease#642348Europe PMC
• Differential effects of levodopa on social cognition in people with Parkinson's disease#658860HAL (France)
• Development of a new methodology for quantitative analysis of rigidity in Parkinson’s disease#685082HAL (France)
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease#800930ClinicalTrials.gov
• Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients#803894ClinicalTrials.gov